Filters

Marie-Hélène Odièvre, Dominique Chretien, Arnold Munnich, Brian H Robinson, Renée Dumoulin, Sahben Masmoudi, Noman Kadhom, Agnès Rötig, Pierre Rustin, Jean-Paul Bonnefont

Human mutation 2006;25(3):323-4

Full Text

Abstract

Results: 1 – 8 / 8

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Dihydrolipoamide Dehydrogenase""[mesh_terms]

Human dihydrolipoamide dehydrogenase (E3) deficiency: Novel insights into the structural basis and molecular pathomechanism.

Lipoamide dehydrogenase (LADH) deficiency: medical perspectives of the structural and functional characterization of LADH and its pathogenic variants.

High amplification rates from the association of two enzymes confined within a nanometric layer immobilized on an electrode: modeling and illustrating example.

An Updated View on the Molecular Pathomechanisms of Human Dihydrolipoamide Dehydrogenase Deficiency in Light of Novel Crystallographic Evidence.

Inhibitors of succinate: quinone reductase/Complex II regulate production of mitochondrial reactive oxygen species and protect normal cells from ischemic damage but induce specific cancer cell death.

Molecular cloning, functional characterization, and subcellular localization of soybean nodule dihydrolipoamide reductase.

Pilot study of radiofrequency ablation therapy without surgical excision for T1 breast cancer: evaluation with MRI and vacuum-assisted core needle biopsy and safety management.

A novel mutation in the dihydrolipoamide dehydrogenase E3 subunit gene (DLD) resulting in an atypical form of alpha-ketoglutarate dehydrogenase deficiency.

Results for
""Dihydrolipoamide Dehydrogenase""[mesh_terms]